<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02029118</url>
  </required_header>
  <id_info>
    <org_study_id>2011SZ0302.2</org_study_id>
    <nct_id>NCT02029118</nct_id>
  </id_info>
  <brief_title>Acupoint Application in Patients With Stable Angina Pectoris (AASAP)</brief_title>
  <acronym>AASAP</acronym>
  <official_title>Effect of Acupoint Application With Herbal Medicine in Patients With Stable Angina Pectoris: Randomized, Controlled,Double Blind Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chengdu University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chengdu University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: acupoint application is effective for managing chronic stable angina pectoris.
      Aim: to evaluate the efficacy and safety of acupoint application on the specific acupoints
      for chronic stable angina pectoris. Design: A Randomized, Controlled,Double Blind trial. 200
      participants will be included. Four arms: herbal medicine application on acupoint group ,
      placebo application on acupoint group , herbal medicine application on non-acupoint group and
      placebo application on non-acupoint group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acupoint application with herbal medicine is a kind of external treatment of traditional
      Chinese medicine and has a long history in China, which is use herbal medicine made of
      plaster and stick to specific acupoints, using the double effects of acupoints and herb to
      treat disease. In China, acupoint application with herbal medicine has been used in clinical
      treatment of angina pectoris, but there is no convincing evidence for the efficacy of
      acupoint application for angina pectoris, due to low methodologic quality and small sample
      size. The investigators designed the Randomized, Controlled, Double Blind clinical trial to
      investigates the efficacy of acupoint application in treating angina pectoris, the purpose of
      this study is to provide the convincing evidence for acupoint application treatment of angina
      pectoris.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Number of angina attacks at 12 weeks</measure>
    <time_frame>at baseline,4, 8weeks after inclusion</time_frame>
    <description>The change frequency of angina attack during every 4-week.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline the severity of angina ( VAS score) at 12 weeks</measure>
    <time_frame>at baseline,4, 8weeks after inclusion</time_frame>
    <description>The VAS score evaluation angina pain severity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline the dosage of nitroglycerin at 12 weeks</measure>
    <time_frame>at baseline,4, 8weeks after inclusion</time_frame>
    <description>Observed reduction in the dose of nitroglycerin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seattle Angina Questionnaire</measure>
    <time_frame>at baseline,4, 8weeks after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>self-rating anxiety scale</measure>
    <time_frame>at baseline,4, 8weeks after inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-rating Depression Scale</measure>
    <time_frame>at baseline,4, 8weeks after inclusion</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Stable Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>Herbal application on acupoint group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Containing the herbal medicine application on the specific acupoints plus foundation treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo application on acupoint</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Not containing herbal medicine application on the specific acupoints plus foundation treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Herbal application on non-acupoint group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Containing the herbal medicine application on the non-acupoints plus foundation treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo application on non-acupoint</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Not containing herbal medicine application on the non-acupoints plus foundation treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Herbal plaster ( styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech)</intervention_name>
    <description>Application containing herbal medicine that mainly include styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech and other herbal medicine.</description>
    <arm_group_label>Herbal application on acupoint group</arm_group_label>
    <arm_group_label>Herbal application on non-acupoint group</arm_group_label>
    <other_name>Herbal medicine application</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>acupoint</intervention_name>
    <description>select acupoint according to traditional Chinese medicine</description>
    <arm_group_label>Herbal application on acupoint group</arm_group_label>
    <arm_group_label>Placebo application on acupoint</arm_group_label>
    <other_name>acupuncture point</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aspirin: 100mg qd; Metoprolol：25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.</intervention_name>
    <description>foundation treatment</description>
    <arm_group_label>Herbal application on acupoint group</arm_group_label>
    <arm_group_label>Placebo application on acupoint</arm_group_label>
    <arm_group_label>Herbal application on non-acupoint group</arm_group_label>
    <arm_group_label>Placebo application on non-acupoint</arm_group_label>
    <other_name>basic treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1.Meet the diagnostic criteria of American College of Cardiology(ACC)/American Heart
        Association (AHA) angina pectoris of coronary heart disease.

        2.35 ≤ age ≤ 85 years, both male and female.

        3.The onset of angina pectoris≥3 months, and the frequency of angina attack≥2 a week.

        4.Patients signed the informed consent

        Exclusion Criteria:

          1. age≤35 or age≥85.

          2. Pregnant women or women in lactation or women of child bearing potential plan to
             conceive in the recent six months.

          3. history of diabetes.

          4. Co-infection or bleeding, allergic.

          5. Currently participating in other clinical trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fanrong Liang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chengdu University of TCM</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yulan Ren</last_name>
    <phone>13689098226</phone>
    <email>912795954@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Affiliated hospital of Chengdu University of TCM</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dehua Li</last_name>
      <phone>18980079361</phone>
      <email>1259362295@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2013</study_first_submitted>
  <study_first_submitted_qc>January 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2014</study_first_posted>
  <last_update_submitted>September 7, 2014</last_update_submitted>
  <last_update_submitted_qc>September 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acupoint Application,Stable Angina Pectoris,herbal medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin Calcium</mesh_term>
    <mesh_term>Ramipril</mesh_term>
    <mesh_term>Metoprolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

